Company news

GuiZhou SanLi Pharmaceutical Co., Ltd. news in 2026

GuiZhou SanLi Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

(603439)"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Renewal of the Acting-in-Concert Agreement by the Controlling Shareholder and Actual Controller

November 6, 2026

(603439)"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Report for Q3 2026

October 27, 2026

(603439)"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 27th Meeting of the 4th Board of Directors

October 27, 2026

(603439)"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge and Pledge of Certain Shares Held by Controlling Shareholder

October 16, 2026

Announcement on Abnormal Fluctuations in Stock Trading

September 14, 2026

Semi-annual Report for 2026

August 27, 2026

Announcement on Reply to the Shanghai Stock Exchange's Information Disclosure Supervisory Inquiry Letter on the Company's 2025 Annual Report

July 23, 2026

Announcement on Implementation of Repurchase and Cancellation of Restricted Shares under the Equity Incentive Plan

July 21, 2026

Announcement on Expected Decrease in Semi-annual Performance for 2026

July 14, 2026

Announcement on Pledging Partial Shares of Person Acting in Concert of Controlling Shareholder

July 2, 2026

Announcement on Implementation of Dividend Distribution for 2025

June 23, 2026

Announcement on Progress in Drug Marketing Authorization Transfer

June 8, 2026

Announcement on Resolutions of the 24th Meeting of the 4th Board of Directors

May 25, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

May 20, 2026

Announcement on the Holding of 2026 Collective Reception Day Activities for Investors of Listed Companies in Guizhou Jurisdiction and Outline of the 2025 Annual Performance Briefing

May 12, 2026

Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Guizhou Jurisdiction and 2025 Annual Performance Briefing and Soliciting Questions

April 27, 2026

Announcement on Daily Related Party Transactions in 2025 and Estimates Daily Related Party Transactions in 2026

April 26, 2026

Announcement on Signing the "Agreement on Transfer of Drug Marketing Authorization Holder"

April 1, 2026

Announcement on Repurchasing and Canceling Some Restricted Stocks to Decrease Capital and Notice to Creditors

March 9, 2026

Announcement on Expected Decrease in Performance for 2025

January 23, 2026

Announcement on Resolutions of the 21st Meeting of the 4th Board of Directors

January 8, 2026